GLP-1 7-36 amide: potential in type 2 diabetes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1247, 2000-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Continuous GLP-1 (7-36) amide effective in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

GLP-1 (7-36) amide confers cardiovascular benefits

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

By Jespersen Maria J   Knop Filip K   Christensen Mikkel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 17-29

Informa Healthcare

Access to resources Recommend Favorite

GLP-1 agonists: a new approach for type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus: Focus on Bile Acid Sequestrants

By >  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite